Mitochondrial Reactive Oxygen Species Control T Cell Activation by Regulating IL-2 and IL-4 Expression: Mechanism of Ciprofloxacin-Mediated Immunosuppression

被引:198
作者
Kaminski, Marcin M. [1 ]
Sauer, Sven W. [2 ]
Klemke, Claus-Detlev [3 ]
Suess, Dorothee [1 ]
Okun, Juergen G. [2 ]
Krammer, Peter H. [1 ]
Guelow, Karsten [1 ]
机构
[1] German Canc Res Ctr, Tumor Immunol Program, Div Immunogenet, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Childrens Hosp, Dept Gen Pediat, Div Inborn Metab Dis, D-6900 Heidelberg, Germany
[3] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venerol & Allergol, D-6800 Mannheim, Germany
关键词
COMPLEX-I; GENE-EXPRESSION; RESPIRATORY INHIBITORS; DOPAMINERGIC-NEURONS; ROTENONE INHIBITION; HYDROGEN-PEROXIDE; HUMAN-LYMPHOCYTES; REDOX REGULATION; INTERLEUKIN-2; TRANSCRIPTION;
D O I
10.4049/jimmunol.0901662
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This article shows that T cell activation-induced expression of the cytokines IL-2 and -4 is determined by an oxidative signal originating from mitochondrial respiratory complex I. We also report that ciprofloxacin, a fluoroquinolone antibiotic, exerts immunosuppressive effects on human T cells suppressing this novel mechanism. Sustained treatment of preactivated primary human T cells with ciprofloxacin results in a dose-dependent inhibition of TCR-induced generation of reactive oxygen species (ROS) and IL-2 and -4 expression. This is accompanied by the loss of mitochondrial DNA and a resulting decrease in activity of the complex I. Consequently, using a complex I inhibitor or small interfering RNA-mediated down regulation of the complex I chaperone NDUFAF1, we demonstrate that TCR-triggered ROS generation by complex I is indispensable for activation-induced IL-2 and -4 expression and secretion in resting and preactivated human T cells. This oxidative signal (H2O2) synergizes with Ca2+ influx for IL-2/IL-4 expression and facilitates induction of the transcription factors NF-kappa B and AP-1. Moreover, using T cells isolated from, patients with atopic dermatitis, we show that inhibition of complex I-mediated ROS generation blocks disease-associated spontaneous hyperexpression and TCR-induced expression of IL-4. Prolonged ciprofloxacin treatment of T cells from patients with atopic dermatitis also blocks activation-induced expression and secretion of IL-4. Thus, our work shows that the activation phenotype of T cells is controlled by a mitochondrial complex I-originated oxidative signal. The Journal of Immunology, 2010,184: 4827-4841.
引用
收藏
页码:4827 / 4841
页数:15
相关论文
共 57 条
[1]   Atopic dermatitis: new immunologic aspects [J].
Avgerinou, Georgia ;
Goules, Andreas V. ;
Stavropoulos, Panayiotis G. ;
Katsambas, Andreas D. .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2008, 47 (03) :219-224
[2]  
BARHAM SS, 1976, CYTOBIOS, V15, P85
[3]  
BARHAM SS, 1976, CYTOBIOS, V15, P97
[4]   Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells [J].
Bengtsson, Å ;
Lundberg, M ;
Avila-Cariño, J ;
Jacobsson, G ;
Holmgren, A ;
Scheynius, A .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (03) :350-360
[5]   Mechanisms of disease: Atopic dermatitis [J].
Bieber, Thomas .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14) :1483-1494
[6]   ROTENONE INHIBITION OF SPINDLE MICROTUBULE ASSEMBLY IN MAMMALIAN-CELLS [J].
BRINKLEY, BR ;
BARHAM, SS ;
BARRANCO, SC ;
FULLER, GM .
EXPERIMENTAL CELL RESEARCH, 1974, 85 (01) :41-46
[7]   THE EFFECT OF BACTERIAL-DNA GYRASE INHIBITORS ON DNA-SYNTHESIS IN MAMMALIAN MITOCHONDRIA [J].
CASTORA, FJ ;
VISSERING, FF ;
SIMPSON, MV .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 740 (04) :417-427
[8]   ANTIOXIDANTS INHIBIT PROLIFERATION AND CELL-SURFACE EXPRESSION OF RECEPTORS FOR INTERLEUKIN-2 AND TRANSFERRIN IN LYMPHOCYTES-T STIMULATED WITH PHORBOL-MYRISTATE ACETATE AND IONOMYCIN [J].
CHAUDHRI, G ;
HUNT, NH ;
CLARK, IA ;
CEREDIG, R .
CELLULAR IMMUNOLOGY, 1988, 115 (01) :204-213
[9]   Assay of mitochondrial respiratory chain complex I in human lymphocytes and cultured skin fibroblasts [J].
Chretien, D ;
Bénit, P ;
Chol, M ;
Lebon, S ;
Rötig, A ;
Munnich, A ;
Rustin, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (01) :222-224
[10]   Immunomodulatory activities of fluoroquinolones [J].
Dalhoff, A .
INFECTION, 2005, 33 (Suppl 2) :55-70